CENTURY THERAPEUTICS, INC. (IPSC)
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026
IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
BRIXMOR PROPERTY GROUP ANNOUNCES SECOND QUARTER 2026 EARNINGS RELEASE AND TELECONFERENCE DATES
Investor Notice: Robbins LLP Informs Investors of the Verra Mobility Corporation Class Action Lawsuit
Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer
IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Kymera Therapeutics Appoints Penny Carlson as Senior Vice President, Development Operations
Mannatech Announces Appointment of Yasir Haider as Chief Financial Officer
Lakefront benoemt dr. Eric Hedrick tot Chief Medical Officer
Tango Therapeutics Announces Proposed $500 Million Public Offering